Here it is: https://www.businessinsider.com/coron
Post# of 36536
Here's more: https://pharmaphorum.com/news/oxford-universi...ine-trial/
And it does use peptides: "This has created a tailor-made peptide that the company hopes will create an antiviral response, while reducing the inflammation that causes respiratory symptoms associated with COVID-19."
I sent this to Joe.